Delivery Order SPE2DB20D2104-SPE2DB24FV18Y
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,204.62, is a Delivery Order for the supply of 4566816334 - Pitavastatin 1 mg Tablet, 90s. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,413.35, is for the delivery of Pitavastatin 2 mg tablets. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,206.24, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the delivery of 4,566,328,625 units of the prescription medication PITAVASTATIN 4 MG TABLET 90S. The contract has an ultimate completion date of November 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
This federal contract award, valued at $1,498.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4564513022 - PITAVASTATIN 2 MG TABLET 90S, a pharmaceutical product, with a completion date of May 7, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,501.41, is for the delivery of Pitavastatin 4 mg tablets. It is a firm fixed-price Delivery Order contract with a period of performance through June 28, 2024. The contract was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of PITAVASTATIN 4 MG TABLET 90S by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.51, is a firm fixed price delivery order placed by the Defense Logistics Agency, a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract has an ultimate completion date of June 5,...
This federal contract award, valued at $1,182.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1002|SPE2DB25FLBJ7) for the supply of 4,568,038,848 units of the prescription medication Pitavastatin 1 mg tablet, with a performance period extending through April 28, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $1,829.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567039797 pitavastatin 2 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.60 firm fixed-price contract is for the delivery of 4,567,157,688 tablets of the medication Pitavastatin 2 mg. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $1,139.86 for the provision of Pitavastatin 2 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025 to...